Original Research

Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC)

Rajpurkar M, Croteau SE, Boggio L, Cooper DL

Journal of Blood Medicine 2019, 10:335-340

Published Date: 18 September 2019